AU2011347802B2 - Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance - Google Patents

Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance Download PDF

Info

Publication number
AU2011347802B2
AU2011347802B2 AU2011347802A AU2011347802A AU2011347802B2 AU 2011347802 B2 AU2011347802 B2 AU 2011347802B2 AU 2011347802 A AU2011347802 A AU 2011347802A AU 2011347802 A AU2011347802 A AU 2011347802A AU 2011347802 B2 AU2011347802 B2 AU 2011347802B2
Authority
AU
Australia
Prior art keywords
nitrooxy
formula
comprised
feed
organic molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011347802A
Other versions
AU2011347802A8 (en
AU2011347802A1 (en
Inventor
Stephane Duval
Maik Kindermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of AU2011347802A1 publication Critical patent/AU2011347802A1/en
Publication of AU2011347802A8 publication Critical patent/AU2011347802A8/en
Application granted granted Critical
Publication of AU2011347802B2 publication Critical patent/AU2011347802B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • C07C203/04Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345Nitrofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C207/00Compounds containing nitroso groups bound to a carbon skeleton
    • C07C207/02Compounds containing nitroso groups bound to a carbon skeleton the carbon skeleton not being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C207/00Compounds containing nitroso groups bound to a carbon skeleton
    • C07C207/04Compounds containing nitroso groups bound to a carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • C07D307/72Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/20Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
    • Y02P60/22Methane [CH4], e.g. from rice paddies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention relates to a method for reducing the production of methane emanating from the digestive activities of a ruminant and/or for improving ruminant animal performance by using, as active compound at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof, which is administrated to the animal together with the feed. The invention also relates to the use of these compounds in feed and feed additives such as premix, concentrates and total mixed ration (TMR) or in the form of a bolus.

Description

WO 2012/084629 PCT/EP2011/072707 USE OF NITROOXY ORGANIC MOLECULES IN FEED FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE 5 The present invention relates to the use of at least one organic molecule substituted at any position with at least one nitrooxy group for reducing the production of meth ane emanating from the digestive activities of ruminants, and/or to improve the ru minant performance. 10 The present invention also relates to animal feed or animal feed compositions and feed additives comprising the above mentioned molecules. The term feed or feed composition means any compound, preparation, mixture, or composition suitable for, or intended for intake by an animal. 15 In the present context, a ruminant is a mammal of the order Artiodactyla that digests plant-based food by initially softening it within the animal's first stomach, known as the rumen, then regurgitating the semi-digested mass, now known as cud, and chewing it again. The process of again chewing the cud to further break down plant matter and stimulate digestion is called "ruminating". 20 Rumen fermentation brings some disadvantages. Methane is produced as a natural consequence of the anaerobic fermentation, which represents an energy loss to the host animal. Carbohydrate makes up 70 - 80% of the dry matter in a typical dairy cattle ration and in spite of this the absorption of carbohydrates from the gastro 25 intestinal tract is normally very limited. The reason for this is the extensive fermenta tion of carbohydrates in the rumen resulting in production of acetate, propionate and WO 2012/084629 - 2 - PCT/EP2011/072707 butyrate as the main products. These products are part of the so called volatile fatty acids, (VFAs). Besides the energy loss, methane is also a greenhouse gas, which is many times more potent than CO 2 . Its concentration in the atmosphere has doubled over the 5 last century and continues to increase alarmingly. Ruminants are the major contribu tors to the biogenic methane formation, and it has been estimated that the preven tion of methane formation from ruminants would almost stabilize atmospheric meth ane concentrations. 10 Furthermore, the assessment of the Kyoto protocol followed by the Copenhagen climate summit in 2009 places increased priority in decreasing methane emissions as part of a multi-gas strategy. The most effective additives currently used for reduc ing the formation of methane contain antibiotics which diminish the proliferation of microorganisms providing hydrogen (H 2 ) to the methanogens (Sauer et al. 1998. 15 American Society of Animal Science; 76: 906-914). However, the effect of antibiotics on the formation of methane has some disadvantages because of rapid adaptation of the microflora and/or resistance development leading to a complete loss of the intended effect within a short period of time (2 to 3 weeks), and because the use of antibiotics is banned in Europe for non therapeutic use. 20 Non antibiotic products (bile acid derivatives) leading to reduction of methane emis sion, when tested using an in vitro rumen simulation model, have recently been pub lished (WO 2010072584). However, the amount required to produce a moderate reduction of methane emission are not compatible with the ruminant feed industry 25 cost constraints. Furthermore, a number of natural plant extracts (Garlic: WO 2009150264, yucca, cinnamon, rhubarb...) have been described in the scientific literature as potent solu tions to reduce methane emission in ruminants based on in vitro experiments. How 30 ever, none of these solutions made it to a commercial product because of side ef fects (residues in milk), because of lack efficacy, when tested in vivo, or because of WO 2012/084629 - 3 - PCT/EP2011/072707 the very large amount of additive which needs to be supplied to the animal to gen erate a significant methane reduction. Under these circumstances there is still a need to develop new substances which 5 reduce the formation of methane and which are in line with reliable and generally accepted practice and not of a medicinal nature. In addition to reducing methane emission, such substances may also contribute to improve ruminant performance by improving the feed conversion ratio, reducing feed intake, improving weight gain, and/or improving carcass, or milk yield. 10 The present inventors now surprisingly found that the compounds specified herein after, have a great potential for use in animal feed in order to essentially reduce the formation of methane without affecting microbial fermentation in a way that would be detrimental to the host animal. Moreover, the compounds of the present invention 15 also have a great benefit regarding overall animal performance as measured by feed conversion ratio, feed intake, weight gain, carcass yield, or milk yield. Said compounds are also more stable than those described in the prior art, safer for the animal and human, lead to persistent methane reduction effect, they do not affect palatability, they can be produced at industrial scale at a cost compatible with the 20 animal nutrition industry, and above all, they do not provoke accumulation of any metabolite in the milk or meat of the supplemented animal, and they are active at very low concentration in the rumen. In particular, the present inventors have observed that the feeding to ruminants of at 25 least one organic molecule substituted at any position with at least one nitrooxy group is very effective for reducing the production of methane emanating from the digestive activities of ruminants without negatively affecting total VFA production, and/or for improving the ruminant performance. Moreover, the present inventors have shown that when the nitrooxy group is replaced by other chemical groups of 30 similar physicochemical properties, the technical effect on methane production is lost demonstrating that the Nitrooxy group is key for the effect on methane reduction of the present invention.
4 It is described in the international patent application Nr.: PCT/EP2010/069338 that nitrooxy-carboxylic acid derivatives are potent inhibitors of rumen methanogenesis in vitro, and also in vivo. Therefore, these molecules are specifically disclaimed from the present invention. 5 The discussion of documents, acts, materials, devices, articles and the like is included in this specification solely for the purpose of providing a context for the present invention. It is not suggested or represented that any or all of these matters formed part of the prior art base or were common general knowledge in the field relevant to 10 the present invention as it existed before the priority date of each claim of this application. Where the terms "comprise", "comprises", "comprised" or "comprising" are used in this specification (including the claims) they are to be interpreted as specifying the 15 presence of the stated features, integers, steps or components, but not precluding the presence of one or more other features, integers, steps or components, or group thereof. The present invention provides the use of at least one organic molecule-substituted at 20 any position with at least one nitrooxy group, or a salt thereof as defined by formula (1) as an active compound in animal feeding for reducing the formation of methane emanating from the digestive activities of ruminants and/or for improving ruminant performance. 25 The invention further provides a method for reducing the production of methane emanating from the digestive activities of ruminants and/or for improving ruminant animal performance, comprising orally administering a sufficient amount of at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (I) to the animal. It is to be understood by oral 30 administration a simple feeding, or manual administration of a bolus. In all embodiments of the present invention, organic molecules substituted at any position with at least one nitrooxy group, or salts thereof are defined by the following compound of formula (1) C:\poi\od\SPEC-968583.docx 4a 0 2 N0 y formula (I) 5 wherein Y is an organic molecule of the following composition: CaHbOdNeSg, wherein a is comprised between 1 and 25, preferably between 1 and 10 b is comprised between 2 and 51, preferably between 2 and 21 10 d is comprised between 0 and 8, preferably between 0 and 6 e is comprised between 0 and 5, preferably between 0 and 3 C:\poi\od\SPEC-968583.docx WO 2012/084629 - 5 - PCT/EP2011/072707 g is comprised between 0 and 3, preferably between 0 and 1, wherein nitrooxy alkanoic acid, and/or derivatives thereof as defined by the formula (II) are excluded, 5 0 2 N, 0 0 R2 z R1 formula (II) wherein u is comprised between 0 and 23 and, wherein if u 0, the carbon chain is a 10 linear, a cyclic, or branched linear or cyclic aliphatic carbon chain which may be mono- or polyunsaturated and in any isomeric form, Z is independently 0, NH, or N-R3, wherein if R1 # H, Z-R1 represents an ester or a secondary amide derivative, R1 is independently, hydrogen or a saturated straight, cyclic or branched chain 15 of an alkyl or alkenyl group containing 1 to 10 carbon atoms, R2 is independently, hydrogen or a saturated straight or branched chain of an alkyl or alkenyl group containing 1 to 23 carbon atoms, and R3 is independently, hydrogen or a saturated straight, cyclic or branched chain of an alkyl or alkenyl group containing 1 to 10 carbon atoms. 20 In another embodiment, preferred compounds of formula (1) according to the present invention are compounds, wherein a is comprised between 1 and 10, preferably, a is comprised between 3 and 8. 25 In another embodiment, preferred compounds of formula (1) according to the present invention are compounds of formula (Ill), WO 2012/084629 - 6 - PCT/EP2011/072707 0 2 N\ 0 R4 n formula (Ill) wherein n is comprised between 0 and 12, preferably comprised between 0 and 6 and, wherein, if n 0, the carbon chain is a linear, a cyclic, or branched aliphatic 5 carbon chain which may be non substituted or substituted with up to 3 hy droxyl-, alkoxy-, amino-, alkylamino-, dialkylamino- or nitrooxy groups, or an alkenyl, or an alkynyl carbon chain mono- or polyunsaturated and in any iso meric form, R4 is independently, hydrogen or a saturated straight, cyclic or branched chain 10 of an alkyl or alkenyl group containing 1 to 12, preferably 1 to 6 carbon at oms, X is hydrogen, R5, R5=N, -OR5, -OCOR5, -NR5R6, -ON02, -COOR5, CONR5R6, -NHSO2R5, or -SO2NHR5, R5 and R6 are independently, hydrogen, C1-C12 straight, branched or cyclic alkyl 15 chain, non substituted or substituted with up to 3 hydroxyl-, alkoxy-, amino-, alkylamino-, dialkylamino- or nitrooxy groups, alkenyl, or alkynyl carbon chain which may be mono or polyunsaturated, and in any isomeric form. For all embodiments of the present invention, it is to be understood that compounds 20 of formula (1) and compounds of formula (III) can be in any isomeric form. It is to be understood in the above definition of compounds of formula (Ill) that when n > 2, the carbon chain can be linear or branched at any position along the carbon chain. In addition, the carbon chain can be branched by multiple branches at differ 25 ent positions along the carbon chain. Moreover, when n > 3, the aliphatic carbon chain may form a cyclic moiety. This cyclic moiety can carry the nitrooxy moiety at any position (2, 3, 4), and it can also be branched at multiple positions by any ali phatic groups. The branched aliphatic groups are preferably, methyl, ethyl or propyl.
WO 2012/084629 - 7 - PCT/EP2011/072707 Moreover, the carbon chain may be further substituted with up to 3 hydroxyl-, alkoxy-, amino-, alkylamino-, dialkylamino- or nitrooxy groups. In the above definition of derivatives of the formula (Ill) a preferred alkyl group is 5 methyl, ethyl, propyl, isopropyl, butyl, sec. butyl, isobutyl, pentyl, neopentyl, hexyl, cyclohexyl, and 2-ethyl-hexyl and octyl. Furthermore any alkyl or alkenyl group con taining three or more carbon atoms can be straight chain, branched, or cyclic. In addition for the straight chain or branched C 2 -C1o-alkenylene group, this is under stood to encompass alkenylene groups with one or (from C 4 ) more double bonds; 10 examples of such alkenylene groups are those of the formulae -CH=CH-, -CH=CH
CH
2 -, -CH=CH-(CH 2
)
3 - and -(CH=CH) 2 -. In another embodiment, more preferred compounds of formula (1) according to the present invention are selected from the list of compounds, and salts thereof com 15 prising: 3-Nitrooxypropanol, racemate-4-Phenylbutane-1,2-diyl dinitrate, 2 (Hydroxymethyl)-2-(nitrooxymethyl)-1 , 3-propanediol, N-Ethyl-3-nitrooxy-propionic sulfonyl amide, 5-Nitrooxy-pentanenitrile, 5-Nitrooxy-pentane, 3-Nitrooxy-propyl propionate, 1,3-bis-Nitrooxypropane, 1,4-bis-Nitrooxybutane, 1,5-bis Nitrooxypentane, 3-Nitrooxy-propyl benzoate, 3-Nitrooxy-propyl hexanoate, 3 20 Nitrooxy-propyl 5-nitrooxy-hexanoate, Benzylnitrate, isosorbid-dinitrate, and N-[2 (Nitrooxy)ethyl]-3-pyridinecarboxamide, 2-Nitro-5-nitrooxymethyl-furan, and Bis-(2 nitrooxyethyl) ether as listed in Table 1: Table 1: Preferred compounds of formula (1) according to the present invention Comp. Molecular structure Chemical name Identifier 1 HO "- O'NO 2 3-Nitrooxypropanol 2
O'NO
2 rac-4-Phenyl butane-1,2-diyl dinitrate 0NO 2 WO 2012/084629 -8- PCT/EP20111/072707 ,O NO2 2-(Hydroxymethyl)-2 3 (nitrooxymethyl)-1, 3 HO O H propanediol HO H N-Ethyl-3-nitrooxy-propionic 4 N sulfonyl amide 50N 5-Nitrooxy-pentanenitrile 6 02N 5-Nitrooxy-pentane 0 7 3-Nitrooxy-propyl propionate 8 02N O O NO 2 1,3-bis-Nitrooxypropane 9 02NsO O-NO2 1,4-bis-Nitrooxybutane 10 02NsO ,ONO 2 1,5-bis-Nitrooxypentane 0 11 0 ' NO2 3-Nitrooxy-propyl benzoate 0 12 -0-- NO 2 3-Nitrooxy-propyl hexanoate 13 0 3-Nitrooxy-propyl 5-nitrooxy 0 2 N, O'-- 0
NO
2 hexanoate 14N2 Benzylnitrate WO 2012/084629 -9- PCT/EP20111/072707 0 2 N H O 15 O , NO 2 isosorbid-dinitrate 0""", 0 H 0 0 16 N N-[2-(Nitrooxy)ethyl]-3 2 pyridinecarboxamide N 1 N 2-Nitro-5-nitrooxymethyl 17 0,OJ N 0 furan II 0 18 N N Bis-(2-nitrooxyethyl) ether 0 0 In another embodiment, even more preferred compounds of formula (Ill) based on the strength of their effect in reducing methane are selected from the list of com pounds, and salts thereof comprising: 3-Nitrooxypropanol, 5-Nitrooxy-pentanenitrile, 5 5-Nitrooxy-pentane, 3-Nitrooxy-propyl propionate, 1,3-bis-Nitrooxypropane, 1,4-bis Nitrooxybutane, 1,5-bis-Nitrooxypentane, 3-Nitrooxy-propyl benzoate, 3-Nitrooxy propyl hexanoate, 3-Nitrooxy-propyl 5-nitrooxy-hexanoate, isosorbid-dinitrate, and N-[2-(Nitrooxy)ethyl]-3-pyridinecarboxamide, and Bis-(2-nitrooxyethyl) ether as listed in Table 2: 10 Table 2: Most preferred compounds of formula (1) according to the present invention WO 2012/084629 - 10 - PCT/EP20111/072707 Comp. Molecular structure Chemical name Identifier 1 HO 'N O'NO 2 3-Nitrooxypropanol 5 0 ON 5-Nitrooxy-pentanenitrile 6 02N 5-Nitrooxy-pentane 0 7 O O NO 2 3-Nitrooxy-propyl propionate 8 02NO 0
NO
2 1,3-bis-Nitrooxypropane 9 02NO O NO0-\12 1,4-bis-Nitrooxybutane 10 02NsO O NO 2 1,5-bis-Nitrooxypentane 0 11 0 -- NO2 3-Nitrooxy-propyl benzoate 0 12 -O-NO2 3-Nitrooxy-propyl hexanoate 13 0 3-Nitr-oxy-propyl 5-nitrooxy 0 2 NK O'NO 2 hexanoate 0 2 N H NO2 15 0,,,. Isosorbid-dinitrate H 0 WO 2012/084629 - - PCT/EP20111/072707 0 16 N 0 N N-[2-(Nitrooxy)ethyl]-3 2 pyridinecarboxamide N 18 N Bis-(2-nitrooxyethyl) ether 0 O In another embodiment, most preferred compound of formula (1) based on the strength of their effect in reducing methane and on the production process is a mix ture of 3-nitrooxy propanol and 1,3-bis-nitrooxypropane. Preferably the ratio 3 5 nitrooxy propanol / 1,3-bis-nitrooxypropane is comprised between 1/10 and 1000/1, more preferably, between 1/5 and 100/1, most preferably, between 1/1 and 10/1. The compounds of the present invention also comprise salts of the nitrooxy organic molecule. Preferred cations for salt preparation may be selected from the group 10 consisting of sodium (Na+), potassium (K+), lithium (Li+), magnesium (Mg2+), cal cium (Ca2+), barium (Ba2+), strontium (Sr2+), and ammonium (NH4+). Salts may also be prepared from an alkali metal or an alkaline earth metal. The compounds of the present invention can be manufactured in principle according 15 to synthetic methods known per se for nitrooxy organic molecules, and/or based on methods as described in the examples. In all these cases appropriate methods to purify the product (compounds of for mula (1)) can be chosen by those skilled in the art, i.e. by column chromatography, 20 or the compound of formula (I), can be isolated and purified by methods known per se, e.g. by adding a solvent such as diethyl-ether or ethyl acetate to induce the WO 2012/084629 - 12 - PCT/EP2011/072707 separation of the crude product from the mixture after reaction, and drying over Na 2
SO
4 of the collected crude product. Methane emission by ruminants can easily be measured in individual animals in 5 metabolic chambers by methods known in the art (Grainger et a/., 2007 J. Dairy Science; 90: 2755-2766). Moreover, it can also be assessed at barn level by an emerging technology using laser beam (McGinn et a/., 2009, Journal of Environ mental Quality; 38: 1796-1802). Alternatively, methane produced by a dairy rumi nant can also be assessed by measurement of VFA profiles in milk according to WO 10 2009/156453. Ruminant performance can be assessed by methods well known in the art, and is usually characterized by feed conversion ratio, feed intake, weight gain, carcass yield, or milk yield. 15 The present invention also relates to the use of at least one organic molecule substi tuted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (1) in combination with at least one additional active substance which shows similar effects with regard to methane formation in the rumen and which is selected 20 from the group consisting of diallyl disulfide, garlic oil, allyl isothiocyanate, deoxy cholic acid, chenodeoxycholic acid and derivatives thereof. Further components that could be given together with the compound according to the present invention are for example yeasts, essential oils, and ionophores like 25 Monensin, Rumensin. It is at present contemplated that diallyl disulfide, garlic oil, allyl isothiocyanate de oxycholic acid, chenodeoxycholic acid and derivatives thereof are independently administered in dosage ranges of for example 0.01-500 mg active substance per kg 30 feed (ppm). These compounds are either commercially available or can easily be prepared by a skilled person using processes and methods well-known in the prior art.
WO 2012/084629 - 1 3 - PCT/EP2011/072707 Ruminating mammals according to the present invention include cattle, goats, sheep, giraffes, American Bison, European bison, yaks, water buffalo, deer, camels, alpacas, llamas, wildebeest, antelope, pronghorn, and nilgai. 5 For all embodiments of the present invention, domestic cattle, sheep and goat are the more preferred species. For the present purposes most preferred species are domestic cattle. The term includes all races of domestic cattle, and all production kinds of cattle, in particular dairy cows and beef cattle. 10 The present invention also relates to the use of at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (I), wherein the methane production in ruminants calculated in liters per kilogram of dry matter intake is reduced by at least 10 % when measured 15 in metabolic chambers. Preferably, methane reduction is at least 15 %, more preferably, at least 20 %, even more preferably, at least 25 %, most preferably, at least 30 %. Alternative methane emission measurements may also be used like using a laser beam or for dairy ruminants, correlating methane production to the VFA profile in milk. 20 The present invention also relates to the use of at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (I), wherein the ruminant feed conversion ratio is reduced by at least 1 % when measured in conventional performance trial. Preferably, the feed 25 conversion ratio is reduced by at least 2 %, more preferably, by at least 2.5 %, even more preferably, by at least 3 %, most preferably, by at least 3.5 %. The present invention also relates to the use of at least one organic molecule substi tuted at any position with at least one nitrooxy group, or a salt thereof as defined by 30 formula (1), wherein the amount of the at least one active compound as defined in formula (1) administered to the ruminant animal is from 1 mg to 10 g per Kg of feed, preferably from 10 mg to 1 g per Kg of feed, more preferably, from 50 mg to 500 mg WO 2012/084629 - 14 - PCT/EP2011/072707 per Kg of feed. For the use in animal feed, however, organic molecules substituted at any position with at least one nitrooxy group, or their salts thereof as defined by formula (1) need not be that pure; it may e.g. include other compounds and deriva tives. 5 As indicated above, the compounds of the present invention are useful as com pounds for feed additives and animal feed compositions for ruminants, and accord ingly are useful as the active ingredients in such feed to reduce methane formation in the digestive tract of the animal, and/or to improve ruminant performance. 10 For the realisation of their use as such ingredients for the feed of ruminants the compounds may be incorporated in the feed by methods known per se in the art of feed formulation and processing. Further aspects of the present invention are therefore formulations, i.e. feed addi 15 tives and animal feed compositions containing compounds as herein above defined. The present invention therefore also relates to a feed composition or a feed additive comprising at least one compound of formula (1) or a salt thereof. Preferably, the feed composition or feed additive is a ruminant base mix. In a preferred embodi ment, the composition is a mineral premix, a vitamin premix including vitamins and 20 minerals or a bolus. The normal daily dosage of a compound according to the invention provided to an animal by feed intake depends upon the kind of animal and its condition. Normally this dosage should be in the range of from about 1 mg to about 10 g, preferably 25 from about 10 mg to about 1 g, more preferably, 50 mg to 500 mg compound per kg of feed. The at least one organic molecule substituted at any position with at least one ni trooxy group, or a salt thereof as defined by formula (1) may be used in combination 30 with conventional ingredients present in an animal feed composition (diet) such as calcium carbonates, electrolytes such as ammonium chloride, proteins such as soya WO 2012/084629 - 15 - PCT/EP2011/072707 bean meal, wheat, starch, sunflower meal, corn, meat and bone meal, amino acids, animal fat, vitamins and trace minerals. Particular examples of compositions of the invention are the following: 5 - An animal feed additive comprising (a) at least one compound selected from table 1 and (b) at least one fat-soluble vitamin, (c) at least one water-soluble vitamin, (d) at least one trace mineral, and/or (e) at least one macro mineral; - An animal feed composition comprising at least one compound selected from table 1 and a crude protein content of 50 to 800 g/kg feed. 10 Therefore, in a preferred embodiment, the present invention relates to a ruminant feed composition or feed additive The so-called premixes are examples of animal feed additives of the invention. A 15 premix designates a preferably uniform mixture of one or more micro-ingredients with diluents and/or carrier. Premixes are used to facilitate uniform dispersion of micro-ingredients in a larger mix. Apart from the active ingredients of the invention, the premix of the invention 20 contains at least one fat-soluble vitamin, and/or at least one water soluble vitamin, and/or at least one trace mineral, and/or at least one macro mineral. In other words, the premix of the invention comprises the at least one compound according to the invention together with at least one additional component selected from the group consisting of fat-soluble vitamins, water-soluble vitamins, trace minerals, and macro 25 minerals. Macro minerals may be separately added to the feed. Therefore, in a particular embodiment, the premix comprises the active ingredients of the invention together with at least one additional component selected from the group consisting of fat 30 soluble vitamins, water-soluble vitamins, and trace-minerals. The following are non-exclusive lists of examples of these components: WO 2012/084629 - 16 - PCT/EP2011/072707 - Examples of fat-soluble vitamins are vitamin A, vitamin D3, vitamin E, and vitamin K, e.g. vitamin K3. - Examples of water-soluble vitamins are vitamin B12, biotin and choline, vitamin B1, vitamin B2, vitamin B6, niacin, folic acid and panthothenate, e.g. Ca-D 5 panthothenate. - Examples of trace minerals are manganese, zinc, iron, copper, iodine, selenium, and cobalt. - Examples of macro minerals are calcium, phosphorus and sodium. 10 As regards feed compositions for ruminants such as cows, as well as ingredients thereof, the ruminant diet is usually composed of an easily degradable fraction (named concentrate) and a fiber-rich less readily degradable fraction (named hay, forage, or roughage). 15 Hay is made of dried grass, legume or whole cereals. Grasses include among others timothy, ryegrasses, fescues. Legumes include among others clover, lucerne or alfalfa, peas, beans and vetches. Whole cereals include among others barley, maize (corn), oat, sorghum. Other forage crops include sugarcane, kales, rapes, and cabbages. Also root crops such as turnips, swedes, mangles, fodder beet, and 20 sugar beet (including sugar beet pulp and beet molasses) are used to feed ruminants. Still further crops are tubers such as potatoes, cassava and sweet potato. Silage is an ensiled version of the fiber-rich fraction (e.g. from grasses, legumes or whole cereals) whereby material with a high water content is treated with a controlled anaerobic fermentation process (naturally-fermented or additive 25 treated). Concentrate is largely made up of cereals (such as barley including brewers grain and distillers grain, maize, wheat, sorghum), but also often contain protein-rich feed ingredients such as soybean, rapeseed, palm kernel, cotton seed and sunflower. 30 Cows may also be fed total mixed rations (TMR), where all the dietary components, e.g. forage, silage and concentrate, are mixed before serving.
WO 2012/084629 - 1 7 - PCT/EP2011/072707 As mentioned above a premix is an example of a feed additive which may comprise the active compounds according to the invention. It is understood that the com pounds may be administered to the animal in different other forms. For example the 5 compounds can also be included in a bolus that would be placed in the rumen and that would release a defined amount of the active compounds continuously in well defined dosages over a specific period of time. The present invention further relates to a method for reducing the production of 10 methane emanating from the digestive activities of ruminants and/or for improving ruminant animal performance, comprising orally administering a sufficient amount of at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (1) with the preferred embodiments described above. 15 Moreover, the invention further relates to a method as described above, wherein the compound of formula (1) is administered to the animal in combination with at least one additional active substance selected from the group consisting of diallyl disul fide, garlic oil, allyl isothiocyanate, deoxycholic acid, chenodeoxycholic acid and de 20 rivatives thereof. The invention also relates to a method as described above, wherein the ruminant animal is selected from the group consisting of: cattle, goats, sheep, giraffes, American Bison, European bison, yaks, water buffalo, deer, camels, alpacas, 25 llamas, wildebeest, antelope, pronghorn, and nilgai, and more preferably from the group consisting of: cattle, goats and sheep. The invention also relates to a method as described above, wherein the amount of the at least one active compound as defined in formula (1) administered to the rumi 30 nant animal is from about 1 mg to about 10 g per kg feed, preferably from about 10 mg to about 1 g, more preferably from 50 mg to 500 mg compound per kg of feed.
WO 2012/084629 - 1 8 - PCT/EP2011/072707 The invention also relates to a method as described above, wherein the methane production in ruminants calculated in liters per kilogram of dry matter intake is re duced by at least 10 % when measured in metabolic chambers. Preferably, meth ane reduction is at least 15 %, more preferably, at least 20 %, even more preferably, 5 at least 25 %, most preferably, at least 30 %. Alternative methane emission meas urements may also be used like using a laser beam or for dairy ruminants, correlat ing methane production to the VFA profile in milk. The invention also relates to a method as described above, wherein the ruminant 10 feed conversion ratio is reduced by at least 1 % when measured in conventional performance trial. Preferably, the feed conversion ratio is reduced by at least 2 %, more preferably, by at least 2.5 %, even more preferably, by at least 3 %, most preferably, by at least 3.5 %. 15 The present invention is further described by the following examples which should not be construed as limiting the scope of the invention.
WO 2012/084629 - 1 9 - PCT/EP2011/072707 Examples Example 1: In vitro test for methane production 5 A modified version of the "Hohenheim Forage value Test (HFT)" was used for test ing the effect of specific compounds on the rumen functions mimicked by this in-vitro system. Principle: 10 Feed is given into a syringe with a composition of rumen liquor and an appropriate mixture of buffers. The solution is incubated at 39 'C. After 8 hours the quantity (and composition) of methane produced is measured and put into a formula for conver sion. 15 Reagents: Mass element solution: - 6.2 g potassium dihydrogen phosphate (KH 2
PO
4 ) 20 - 0.6 g magnesium sulfate heptahydrate (MgSO 4 * 7H 2 0) - 9 ml concentrated phosphoric acid (1 mol/I) - dissolved in distilled water to 1 1 (pH about 1.6) Buffer solution: - 35.0 g sodium hydrogen carbonate (NaHCO 3 ) 25 - 4.0 g ammonium hydrogen carbonate ((NH 4
)HCO
3 ) - dissolved in distilled water to 1 1 Trace element solution: - 13.2 g calcium chloride dihydrate (CaCl 2 * 2H 2 0) - 10.0 g manganese(II) chloride tetrahydrate (MnC1 2 * 4H 2 0) 30 - 1.0 g cobalt(II) chloride hexahydrate (CoCl 2 * 6H 2 0) - 8.0 g iron(ll) chloride (FeCl 3 * 6H 2 0) - dissolved in distilled water to 100 ml WO 2012/084629 - 20 - PCT/EP2011/072707 Sodium salt solution: - 100 mg sodium salt - dissolved in distilled water to 100 ml Reduction solution: 5 - first 3 ml sodium hydroxide (c = 1 mol/), then 427.5 mg sodium sulfide hy drate (Na 2 S * H 2 0) are added to 71.25 ml H 2 0 - solution must be prepared shortly before it is added to the medium solution Procedure: 10 Sample weighing: The feed stuff is sieved to 1mm - usually TMR (44 % concentrate, 6 % hay, 37 % maize silage and 13 % grass silage) - and weighed exactly into 64 syringes. 4 of these syringes are the substrate controls, which display the gas production without 15 the effect of the tested compounds. 4 other syringes are positive control, in which bromoethane sulfonate has been added to 0.1 mM. When needed, 4 syringes con tain a carrier control (if the test compounds need a carrier). The remaining syringes contain the test substances, by groups of 4 syringes. 20 Preparation of the medium solution: The components are mixed in a Woulff bottle in following order: - 711 ml water - 0.18 ml trace element solution - 355.5 ml buffer solution 25 - 355.5 ml mass element solution The completed solution is warmed up to 39 *C followed by the addition of 1.83 ml sodium salt solution and the addition of reduction solution at 36 0 C. The rumen liquor is added, when the indicator turns colourless. 30 Extraction of the rumen liquor: 750 ml of rumen liquor are added to approximately 1,400 ml of medium solution un der continued agitation and C0 2 -gassing.
WO 2012/084629 - 21 - PCT/EP2011/072707 Filling the syringes, incubation and determining gas volumes and VFA values: The diluted rumen fluid (24 ml) is added to the glass syringe. The syringes are then incubated for 8 hours at 39 'C under gentle agitation. After 8 hours, the volume of 5 gas produced is measured, and the percentage of methane in the gas phase is de termined by gas chromatography. Results The food fermented was artificial TMR (44 % concentrate, 6 % hay, 37 % maize si 10 lage and 13 % grass silage). The compounds produced as described in examples 2 to 14 were added to the fermentation syringes to a concentration of 2 to 0.005 % of dry matter (DM). The results are presented in the following table. Table 3: Methane reduction effect resulting from the average of two experiments 15 with some compounds according to the present invention (an integer in the column effect on methanogenesis change (%) means a reduction in methane produced when compared to control; no value means that the concentration was not tested) Structure effect on methanogenesis (%) 2 % 1 % 0.5 0.25 0.1 0.05 0.01 0.00 DM DM % % % % % 5 % DM DM DM DM DM DM HO ONO 100 100 100 100 79 20
ONO
2 10 4 ON0 2
ONO
2 HO OH 85 6
HO
WO 2012/084629 -22 - PCT/EP20111/072707 H N99 99 24 10 2 2 02NO N 99 95 12 7 NO2 100 100 33 4 0 O NO2 100 100 21 6 0 2 NO'* ON0 2 99 100 98 29 0 2N 0ONO2 100 100 92 16 0 2 NO0 X" ONO 2 100 100 45 6 0 O99 99 11 0 O N 0ON02 98 99 42 0 N0 2 0 " N0 NO2 100 100 37 3 NN H / N0 2 0". 0 100 SH 0 WO 2012/084629 -23- PCT/EP20111/072707 0 N
ONO
2 100 N N O OsN 100 99 64 3 O o Example 2: Comparative example: in vitro test for methane production. 5 The same in vitro assay as described in example 1 has been performed with a se ries of molecules, wherein the nitrooxy group has been replaced by different organic groups. Moreover, the inorganic salt Na N03 has also been tested. See results in Table 4. This data demonstrates that a significant methane reduction activity is only observed when the Nitrooxy group is present in the series. 10 Table 4: Methane reduction effect resulting from the average of two experiments with 3-nitrooxypropanol according to the present inventionin comparison with similar compounds in which the nitrooxy group has been replaced. (An integer in the col umn effect on methanogenesis change (%) means a reduction in methane produced 15 when compared to control; no value means that the concentration was not tested) Structure effect on methanogenesis (%) 2%DM 0.5% 0.1 % 0.05% 0.01 % DM DM DM DM HO ONO2 100 100 100 79 2 HO
~NO
2 8 WO 2012/084629 - 24 - PCT/EP2011/072707 6 0 HOO 2 HO '
NH
2 NaNO3 23 2 Example 3: Synthesis of 3-Nitrooxypropanol: HO "' Br AgNO 3 HO - ONO 2 138.99 121.04
C
3
H
7 BrO C 3
H
7 0 4 N 5 50.1 mmol 3-Bromopropanol dissolved in 100 ml acetonitrile and 125.25 mmol silver nitrate were added into a flask protected from light. This suspension was stirred for 21 hours at 70 *C. After cooling to room temperature the suspension was filtrated and concentrated in vacuo. The residue was dissolved in Water and extracted two 10 times with TMBE. The organic phases were washed with water und brine, com bined, dried over Na 2
SO
4 and the solvent was removed in vacuo leaving 5.63 g. The crude product was purified by flash chromatography on silica gel using hep tane/ethyl acetate 2:1; Yield: 4.82 g (38.8 mmol, 77.4 %). 15 Example 4: Synthesis of 2-(Hydroxymethyl)-2-(nitrooxymethyl)-1,3-propanediol: "" "'TI~I""IE% D _ T I~I II f ^A1 I A I "4 WO 2012/084629 - 25 - PCT/EP2011/072707 Br ON0 2 AgNO 3 HO OH HO OH HO HO 199.05 181.05 CHglBrO3
C
5
H,
1 0 6 N 5 mmol 2-(Bromomethyl)-2-(hydroxymethyl)-1,3-propanediol dissolved in 20 ml ace tonitrile and 15 mmol silver nitrate were added into a flask protected from light. This 5 suspension was stirred for 24 hours at 70 *C. After cooling to room temperature the suspension was filtrated and the solvent was removed in vacuo leaving 3.05 g. The crude product was purified by flash chromatography on silica gel using di chloromethane/methanol 50:1; Yield: 0.36 g (1.99 mmol, 40.2 %). 10 Example 5: Synthesis of rac-4-Phenylbutane-1,2-diyl dinitrate: ACN + 1 2 + A g N o A C O 2 0____0N0 2 132.21 ON0 2 ClOH12 256.22
C
10
H
12
N
2 06 15 7.5 mmol 4-Phenyl-1-buten dissolved in 40 ml acetonitrile, 20.3 mmol silver nitrate and 7.5 mmol lode were added into a flask protected from light. This suspension was stirred for 30 minutes at 25 *C and then for 16 hours at 79 *C. After cooling to room temperature the suspension was filtrated and washed with Ethyl acetate. The filtrate was extracted three times with water and washed brine, dried over Na 2
SO
4 20 and the solvent was removed in vacuo leaving 1.92 g. The crude product was purified by flash chromatography on silica gel using Hex ane/Ethyl acetate 10:1; Yield: 0.52 g (2.03 mmol, 27 %). 25 Example 6: Synthesis of N-Ethyl-3-nitrooxy-propionic sulfonyl amide: WO 2012/084629 - 26 - PCT/EP2011/072707 H 2 ANH 2 + CISo' C N SO C + HCI 45.08 177.00 186.1
C
2
H
7 N C 3
H
8
O
2 Cl 2 S C 5
H
12
NCISO
2 H H NSO Cj + AgNo 3 ' 2 185.6 212.1
C
5
H
1 2 CINSo 2 CH 1 2 0SN 2 s In a flask 17 mmol 3-chloropropionic sulfonyl chloride were dissolved in 5 ml Tetra 5 hydrofurane. 33.3 mmol Ethylamine were added over a period of 45 minutes. After that, the solvent was removed in vacuo. The residue was dissolved in water, ex tracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over Na 2
SO
4 and the solvent was removed in vacuo. 10 The residue was dissolved in 50 ml acetonitrile and 60 mmol silver nitrate were added into a flask protected from light. This suspension was stirred for 41 hours at 70 0C. After cooling to room temperature the suspension was filtrated and concen trated in vacuo. The residue was dissolved in dichloromethane and extracted with Water. The water phase was washed again with two times with dichloromethane. 15 The combined organic phase was washed with water and brine, dried over Na 2
SO
4 and the solvent was removed in vacuo; Yield: 3.05 g (14.5 mmol; 84.5 %). Example 7: Synthesis of 3-Nitrooxy-propyl propionate: 0 O 2.3/Ci + HO' -'ONO 2 O ONO2 92.53g/mol 121.04g/mol.
C
3
H
5 cIO C3HO4N 177.16g/mol 20
C
6
H
1
NO
5 9.1 mmol Propionyl chloride were dissolved in 10 ml TMBE and cooled to 3 *C. 8.25 mmol 3-Nitrooxypropanol and 9.1 mmol triethylamine in 5 ml TMBE were dropped over a period of 5min at 3 to 6 *C. After 2 hours and 30 minutes stirring WO 2012/084629 - 27 - PCT/EP2011/072707 without cooling the reaction mixture were extracted with 1 N HCI, twice with water, washed with brine, dried over Na 2
SO
4 and the solvent was removed in vacuo leav ing 1.35 g. 5 The crude product was purified by flash chromatography on silica gel using Hex ane/Ethyl acetate 4:1, Yield: 1.14 g (6.4 mmol, 78.0 %). Example 8: Synthesis of 3-Nitrooxy-propyl benzoate: 0 0 e CI " HOOONO2 e O ONO 2 140.57g/mol 121.04g/mol 225.20g/mol 10 CH 5 CIO c 3
H
7 0 4 N C 1 0
H
11
NO
5 16.5 mmol 3-Nitrooxypropanol dissolved in 10 ml TMBE and 18.2 mmol Triethyl amine were cooled to 3 *C. 18.2 mmol benzoylchloride in 5 ml TMBE were dropped over a period of 7 minutes at 3 to 6 0 C. After 24 hours and 30 minutes stirring with 15 out cooling, the reaction mixture was extracted with sated. NaHCO 3 , water, 1N HCI, twice with water, washed with brine, dried over Na 2
SO
4 and the solvent was re moved in vacuo leaving 3.3 g. The crude product was purified by flash chromatography on silica gel using a gradi 20 ent of Hexane/Ethyl acetate from 1:0 to 2:1; Yield: 0.66 g (2.9 mmol, 17.7 %). Example 9: Synthesis of 3-Nitrooxy-propyl hexanoate: 0 0 CI + HO '-ONO2 O NX'_ONO2 134.61g/mol 121.04g/mol 219.24g/mol 25 CH,,CIO C 3
H
7 0 4 N CHNO, WO 2012/084629 - 28 - PCT/EP2011/072707 20 mmol 3-Nitrooxypropanol dissolved in 10 ml Diethylether and 20 mmol Triethyl amine were cooled to 0 *C. 18.2 mmol hexoylchlorid were dropped over a period of 5 minutes at 0 to 50C. After 19 hours stirring without cooling, the reaction mixture was extracted with 1 N HCl, twice with water, washed with brine, dried over Na 2
SO
4 5 and the solvent was removed in vacuo leaving 3.1g. The crude product was purified by flash chromatography on silica gel using Hep tane/Ethyl acetate 4:1, Yield: 2.4 g (10.9 mmol, 60.0 %). 10 Example 10: Synthesis of 3-Nitrooxy-propyl 5-nitrooxy-hexanoate: o 0 O2NO Ici + HO ' ONO2 0 2NO O -- ONO2 181.58g/mol 121.04g/mol 266.21g/mol
C
5
H
8 CINO4 c 3
H
7 0 4 N C 8
H
14
N
2
O
8 20 mmol 3-Nitrooxypropanol dissolved in 10 ml Diethylether and 20 mmol Triethyl 15 amine were cooled to 0 0C. 18.2 mmol 5-nitrooxypentoylchlorid were dropped over a period of 5min at 0 to 50C. After stirring over night without cooling, the reaction mix ture was extracted with 1N HCI, twice with water, washed with brine, dried over Na 2
SO
4 and the solvent was removed in vacuo. 20 The crude product was purified by flash chromatography on silica gel using Hep tane/Ethyl acetate 4:1; Yield: 2.4 g (9.1 mmol, 50.0 %). Example 11: Synthesis of Benzylnitrate: Br AgNO 3 " ONO 2 171.04 153.14
C
7
H
7 Br C 7
H
7 N0 3 25 WO 2012/084629 _ 29 - PCT/EP2011/072707 10 mmol Benzylbromide dissolved in 80 ml acetonitrile and 25 mmol silver nitrate were added into a flask protected from light. This suspension was stirred for 5 hours at 70 *C. After cooling to room temperature the suspension was filtrated and con centrated in vacuo. The residue was dissolved in dichloromethane and extracted 5 with Water. The water phase was washed again with two times with dichloro methane. The combined organic phase was washed with water and brine, dried over Na 2
SO
4 and the solvent was removed in vacuo; Yield: 1.55 g (10.1 mmol; 100%). 10 Example 12: Synthesis of 1,3-bis-Nitrooxy-propane: AgNO 3 Acetonitrile 0 OO O'O 7000, 2 h To a solution of 1,3-dibromopropane (2.00 g, 1.0 eq) in 20.0 mL of dry acetonitrile 15 was added Silver Nitrate (3.70 g, 2.2 eq). The reaction mixture was heated at 70 0C for 2 hours in the dark. The resulting mixture was filtered off through celite and the filtrate was concentrated. The residue was dissolved into water (50.0 mL), extracted with dichloromethane (2 x 50.0 mL), dried over magnesium sulfate and solvents were evaporated under vacuum to afford 1.44 g of compound as a colorless liquid 20 (Yield = 87 %). Example 13: Synthesis of 1,4-bis-Nitrooxy-butane: 0 AgNO 3 I I Br Br ON, O" -'' O'N..O Acetonitrile 1 70c. 2 h 25 To a solution of 1,4-dibromobutane (2.00 g, 1.0 eq) in 20.0 mL of dry acetonitrile was added Silver Nitrate (3.50 g, 2.2 eq). The reaction mixture was heated at 70 0C for 2 hours in the dark. The resulting mixture was filtered off through celite and the WO 2012/084629 - 30 - PCT/EP2011/072707 filtrate was concentrated. The residue was dissolved into water (50.0 mL), extracted with dichloromethane (2 x 50.0 mL) and dried over magnesium sulphate. Solvents were evaporated under vacuum to afford 1.49 g of compound as a colorless liquid (Yield = 89 %). 5 Example 14: Synthesis of 1,5-bis-Nitrooxy-pentane 0 0 AgNO 3 | 1| Acetonitrile 0 70'C, 2 h 10 To a solution of 1,5-dibromopentane (2.00 g, 1.0 eq) in 20.0 mL of dry acetonitrile was added Silver Nitrate (3.30 g, 2.2 eq). The reaction mixture was heated at 70 'C for 2 hours in the dark. The resulting mixture was filtered off through celite and the filtrate was concentrated. The residue was dissolved into water (50.0 mL), extracted with dichloromethane (2 x 50.0 mL) and dried over magnesium sulphate. Solvents 15 were evaporated under vacuum to afford 1.38 g of compound as a colorless liquid (Yield = 82 %). Example 15: Synthesis of 5-Nitrooxy-pentanenitrile: 0 N AgNO 3 N Br Acetonitrile 0 0 20 70'C, 2 h To a solution of 5-bromovaleronitrile (4.00 g, 1.0 eq) in 40.0 mL of dry acetonitrile was added Silver Nitrate (4.60 g, 1.1 eq). The reaction mixture was heated at 70 0 C for 2 hours in the dark. The resulting mixture was filtered off through celite and the 25 filtrate was concentrated. The residue was dissolved into water (50.0 mL), extracted with dichloromethane (2 x 50.0 mL) and dried over magnesium sulphate. Solvents were evaporated under vacuum to afford 3.56 g of compound as a colorless liquid (Yield = 99 %).
WO 2012/084629 PCT/EP2011/072707 -30b Example 16: Synthesis of Bis-(2-nitrooxyethyl) ether Br O Br AgNQ 3 , ON. O O N..O 1l 11 0 0 231.92g/mol 196.12g/mol
C
4 H.Br 2 O C 4
HAN
2 0 7 16.05 mmol Bis (2-bromoethyl) ether dissolved in 30ml acetonitrile and 40.13 mmol 5 silver nitrate were added into a flask protected from light. This suspension was stirred for 16h at 700C. After cooling to room temperature the suspension was fil trated and concentrated in vacuo. The residue was dissolved in Water and extracted two times with TMBE. The organic phases were washed with water und brine, com bined, dried over Na2SO4 and the solvent was removed in vacuo leaving 3.06g. 10 The crude product was filtrated over silica gel using heptane/ethyl acetate 1:1; Yield: 2.94g (15.Ommol, 93.4%).
WO 2012/084629 - 31 - PCT/EP2011/072707 Example 17: In vivo effect of 3-Nitrooxypropanol compared to ethyl-3 nitrooxypropionate: 5 Material and methods 10 sheep were cannulated in the rumen. The trial started one month after the surgi cal operation. There were 3 treatments: control, additive 1 and additive 2, both at a single dose. Additive I is ethyl-3-nitrooxypropionate, and additive 2 is 3 nitrooxypropanol of the present invention. The experimental design consisted of a 3 10 x 3 Latin square with 3 sheep per treatment in each period and 3 consecutive peri ods. Each period included 28 days of adaptation to the treatment plus two consecu tive days of methane measurements in chambers and collection of rumen samples. Over the course of the adaptation phase, a medium term one day methane meas urement was done at day 14. In addition, during days 22 and 23 samples of alfalfa 15 hay and oats, placed in nylon bags, were incubated in the rumen of sheep to deter mine the dry matter ruminal degradation. During the two days of methane meas urements in chambers (days 29 and 30) rumen contents samples were collected two hours after the morning feeding, sub-sampled and immediately frozen prior DNA extraction and determination of volatile fatty acids and ammonia nitrogen concentra 20 tion. Experimental animals were randomly allocated in three sub-groups of 3 ani mals each and were randomly assigned one of the three treatments (control, addi tive 1 and additive 2). The 3 sub-groups started the adaptation to the diet with a gap of two days so they were in the same adaptation day prior methane measurement in the chambers. Animals were individually held in cages with constant access to fresh 25 water. A diet consisting of alfalfa hay chopped at 15-20 cm and oats in a 60:40 ratio plus mineral-vitamin supplement was provided to the animals at approximately 1.1 times the energy maintenance level in two equal meals at 9'00 and 14'00 hours. Fresh matter intake was monitored daily for each animal throughout the trial. The additive was provided twice a day through the ruminal cannula at the same time 30 as the feed. The corresponding amount to each additive (100 mg per animal and day for both additives) was pipetted into 10 grams of grounded oats and wrapped in cellulose paper immediately before it was placed in the rumen. Since the active WO 2012/084629 - 32 - PCT/EP2011/072707 molecule is volatile the previously mentioned procedure was carried out in a cold room at 41C. Methane measurement and samples collection 5 A set of four methane chambers was used. On days 14, 29 and 30 animals were placed in the chambers for methane measurements. Each chamber measured 1.8 m wide x 1.8 m deep x 1.5 m tall. Chamber air temperature was maintained be tween 15 and 20'C. Within each chamber, the animals were individually restrained in the same cages as during adaptation. Interruptions occurred daily at 09'00 hours, 10 when the chamber floor was cleaned, and the animals were fed. These interruptions had little impact on the daily methane emissions because fluxes were calculated three times per day and then averaged to derive the 23-h emission value. Airflow and concentration of methane was measured for the inflow and outflow ducts of each chamber. Air velocity was continuously monitored over the day in the exhaust 15 duct for each chamber. The air stream in each of the 4 ducts (chambers 1, 2 and 3 and background) was sub-sampled, and methane concentration was measured con tinuously using a gas analyzer ADM MGA3000 (Spurling works, Herts, UK). It took 11 min to sequentially sample the airflow in all inflow and exhausts ducts in the chambers (3 min in chambers 1, 2, 3, 2 min for background). In summary, the flux of 20 methane for each chamber was calculated for each measuring day from the differ ence of fresh-air inflow and chamber exhaust methane concentrations and mean air velocities. Rumen samples analysis 25 Samples of rumen contents were freeze-dried and thoroughly mixed by physical disruption using a bead beater (Mini-bead Beater, BioSpec Products, Bartlesville, OK, USA) before DNA extraction, which was performed from approximately 50 mg of sample using the QIAamp@ DNA Stool Mini Kit (Qiagen Ltd, West Sussex, UK) following the manufacturer's instructions with the modification that a higher tempera 30 ture (95 0 C) was used for lysis incubation. DNA samples were used as templates for quantitative real-time PCR (qPCR) amplification. The abundance of total bacteria, total protozoa and total methanogenic archaea were quantified by Real Time - PCR WO 2012/084629 - 33 - PCT/EP2011/072707 (qPCR). Different primer sets were used to amplify 16S rRNA gene-targeted total bacteria (Maeda et al., 2003), and 18S rRNA gene-targeted total protozoa (Syl vester et al 2005). Primers designed for the detection of methanogenic archaea were targeted against the methyl coenzyme-M reductase (mcrA) gene (Denman et 5 al., 2007). The amplifications mixture contained 11.5 pl 2X RT-PCR supermix Bio Rad (Bio-Rad Laboratories Inc., Hercules, CA, USA), 0.4 p| of each primer and 0.5 pI of sample in a final volume of 23 pl. The amplification efficiency was evaluated for each pair of primers with the following program: a 5 min cycle at 950 C, 40 cycles at 950 C for 15s, 60* C for 30s, 720 C for 55s and, 750 C during 6s for fluorescent 10 emission measures. The melting curve was built by increasing temperature from 550 C to 95* C and readings were taken every 50 C. Amplification of each target group was carried out with the following program: a 5 min cycle at 950 C, 40 cycles at 950 C for 15s, 15s at 600 C and 720 C for 45s (including the fluorescence emission measuring) and a melting curve with a set point temperature of 450 C and end tem 15 perature of 950 C. The absolute amount of bacteria, protozoa and methanogenic archaea, expressed as the number of DNA copies, was determined by using the plasmid pCR*4-TOPO (Invitrogen T M , Carlsbad, CA, USA) as standard. The PCR product obtained using the respective set of primers was purified and then cloned into pCR* 4-TOPO* plasmid (Invitrogen
TM
, Carlsbad, CA, USA) to produce recombi 20 nant plasmids. A single colony, verified for the expected insert using PCR, was grown in solid media with antibiotics and X-gal overnight. Afterwards, a screening of transformed E. co/i colonies was done and some of the positive ones were randomly selected. After checking the presence of the inserted fragment in the colonies by PCR, massive culture of positive colonies was done in liquid media overnight. Plas 25 mids belonging to these cultures were extracted using the Pure LinkTM Miniprep kit (Invitrogen T M , Carlsbad, CA, USA) and then sequenced to verify the presence of the fragment inserted. The number of 16S rRNA gene copies present in the plasmid extracts was calculated using the plasmid DNA concentration and the molecular mass of the vector with the insert. The concentrated plasmid was serially diluted 30 (10-fold) to provide a range of 108 to 102 copies to generate a standard curve. A relative abundance quantification was used for methanogenic archaea and pro tozoa as described by Denman and McSweeny (2006) using the 16sRNA as refer- WO 2012/084629 - 34 - PCT/EP2011/072707 ence gene. Volatile fatty acids were analysed by gas chromatography and ammonia N concentration by colorimetry following the protocols established in our laboratory (Martln-Garcia et al., 2004). 5 Rumen degradability Three grams of 2 mm ground feed were placed in 5 cm x 10 cm nylon bags with a pore size of 50 pm (#R510 Ankom in situ bags, Macedon NY). The two ingredients used in the animals' diets were tested: oats and alfalfa hay. Bags with oats were incubated in the rumen for 24 hours, while those with alfalfa hay for 48 hours. The 10 incubations times were chosen based on average residing times in the rumen of different feedstuffs. On days 22 and 23 two bags per feed and animal and period were. Bags were placed in the rumen immediately before the morning feeding. At 24 or 48 hours they were taken out of the rumen, washed with cold water and frozen at -20"C. At the end of every period the frozen bags were washed in a washing ma 15 chine using a short cold water program including two bags per feed that had not been incubated in the rumen to account for solubility. After washing, the bags were placed in the oven at 601C for 48 hours. Rumen degradability (%) was calculated as the loss of dry matter over the incubation time. 20 Experimental animals care All management and experimental procedures to the sheep were carried out by trained personnel in strict accordance with the Spanish guidelines (Act No. 1201/2005 of 10 October 2005) for experimental animal protection. The tempera ture, humidity and air turn out in chambers were carefully monitored considering the 25 animal welfare conditions. CO 2 concentration was also continuously monitored in order to keep it within the limits that ensured a good air quality and renovation rate. Animals didn't show any stressed behaviour while they were allocated in chambers. Statistical analysis 30 Individual methane emissions, VFA profiles, ratio of acetate to propionate, ammonia N concentration, log 10 transformations of concentration of total bacteria, total proto zoa and methanogenic archaea and the relative abundance were analyzed for effect WO 2012/084629 - 35 - PCT/EP2011/072707 of including the additive. The standard error of the mean (SEM) was computed for each analysis. Means were further compared using a least significant difference (LSD) test. 5 Results Dry matter intake was not affected (P>0.05) by the treatment and only slight reduc tion in intakes were observed when the animals were introduced in the methane chambers on days 14 and 30. 10 As described for intakes, the body weight (as an average of weights recorded prior and after chamber measurements) was not different (P>0.05) among treatments (Table 5). Methane emissions, expressed as litres per kg of fresh matter intake, were significantly (P=0.020) reduced on day 14 when both additives were incorpo 15 rated in the diet. The reduction observed against the control was 14 % and 23 %, respectively, for additives 1 and 2. When methane emissions were recorded two weeks later, on days 29 and 30, there was still a numerically reduction, although it did not reach the statistical significance (P=0.061 and 0.183 for days 29 and 30, re spectively). If the measurements recorded during the last two consecutive days are 20 pooled together the effect of the addition shows a similar tendency (P=0.092) as the values considered separately. Table 5. Effect of the addition of additives 1 and 2 on body weights, intakes and methane emissions by sheep measured on days 14, 29 and 30 after commencing 25 the treatment. Additive Additive P Time Item Control 1 2 SEM value day 14 intake, kg/day 0.819 0.849 0.867 CH4 1, day 24.6 21.9 20.0 CH4 1/kg intake 29.9 25.6 22.5 2.31 0.020 WO 2012/084629 - 36 - PCT/EP20111/072707 day 29 intake, kg/day 0.856 0.944 0.922 CH4 1, day 22.0 20.9 18.3 CH4 1/kg intake 25.8 21.7 19.6 2.12 0.061 day 30 intake, kg/day 0.760 0.925 0.747 CH4 1, day 22.7 21.8 19.7 CH4 I/kg intake 29.8 23.2 25.6 2.34 0.183 days 29-30 intake, kg/day 0.780 0.933 0.823 CH4 1, day 21.8 21.5 19.1 CH4 I/kg intake 28.2 22.6 23.1 2.17 0.092 a Values in a row not sharing a common superscript letters significantly differ, P<0.05. * Average of weighing prior and after chamber measurements. SEM: Standard Error of the Means 5 Table 6. Effect of the addition of additive 1 and 2 on volatile fatty acid profile (mol/100 mol), ammonia N concentration (mg/1 00 ml) and dry matter degradation (DMD, %) of oats (24 hours) and alfalfa hay (48 hours) in the rumen of sheep. Control Additive 1 Additive 2 SEM P value Acetate 69.2c 67.5 64.5a 0.742 0.007 Propionate 14.3a 16.6a 17.5 1.030 0.004 Butirate 2.08 2.05 2.11 0.818 0.353 iso-butirate 11.2 10.1 12.3 0.201 0.995 Valerate 1.91 1.94 1.82 0.194 0.100 iso-valerate 1.47 1.79 1.82 0.281 0.908 Total 57.4 58.2 57.1 5.193 0.995 C2/C3 4.91 4.09a 3.895 0.262 0.002
N-NH
3 100.1 97.3 104.1 9.157 0.924 WO 2012/084629 - 37 - PCT/EP2011/072707 DMD alfalfa hay 78.6 78.3 78.8 1.22 0.725 DMD oats 74.2 74.0 70.6 2.02 0.167 "Values in a row not sharing a common superscript letters significantly differ, P<005. SEM: Standard Error of the Means 5 The study of the rumen fermentation parameters from rumen samples collected on days 29 and 30 showed a shift in the fermentation pathways (Table 5) towards a more propionate type profile in the rumen of animals receiving both additives in comparison to the control. As a consequence, in both treatments the acetate to propionate ratio was significantly (P=0.002) reduced. The concentration of ammonia 10 N was similar among treatments and within the range expected for the diet supplied to the animals. The in sacco degradation study on days 2 2 nd and 2 3 rd showed no effect of the addi tive treatment on the rumen degradability of both alfalfa hay and oats. 15 Table 7. Effect of the addition of additives 1 and 2 on the concentration (log copy gene numbers/g fresh matter) of total bacteria (16S rRNA), protozoa (18S rRNA) and methanogenic archaea (mcrA gene) in the rumen of sheep. The relative abun dance (ACt) in relation to total bacteria is also shown for protozoa and methano gens. Control Additive 1 Additive 2 Error P value Total bacteria 7.45*1010 9.08*10 1 9.74*1010 loglo 10.8 10.9 11.0 0.123 0.607 Total protozoa 2.84*1010 1.87*1010 2.51*10 log 10 10.4 10.2 10.2 0.212 0.702 ACt 1.65 1.58 1.55 0.267 0.984 WO 2012/084629 - 38 - PCT/EP20111/072707 Archaea 3.54*10" 2.86*10" 2.86*10T log10 8.54 8.45 8.34 0.133 0.511 ACt 0.028 0.022 0.020 0.005 0.602 Total and relative concentration of the analysed microbial groups in the rumen showed no difference (P>0.05) among treatments. When the abundance of both protozoa and methanogenic archaea were expressed relative to total bacteria the 5 same lack of effect was observed. Conclusions The use of both additives resulted in a significant reduction of methane production and, according to the VFA profiles, a shift in the metabolic pathways involved in H 2 10 transferring was promoted by additives as well. The objective of this trial was to con firm whether the treatment of animals for a month showed a persistence of the re sults observed over two weeks treatment. This is essential when assessing the suit ability of the practical use of a feed additive. In this study both additives showed ef fect over a month treatment in methane emissions that was further confirmed by a 15 shift in the fermentation pattern. On the other hand, a change in the fermentation pattern might be not only due to a reduction in methane production but also to a lower fibre degradation which, in turn, would produce less acetate and therefore lowered acetate to propionate ratio. In order to rule out this occurring, a rumen degradability assessment was carried out 20 by incubating nylon bags with both oats and alfalfa hay in the rumen of the animals. The results showed no such effect on dry matter degradation which is also sup ported by the same bacterial and protozoa biomass recorded in animals receiving the additives compared to those with no treatment. 25 Example 18: In vivo effect of 3-Nitrooxypropanol in dairy cows WO 2012/084629 - 39 - PCT/EP2011/072707 Material and Methods Animals: Six rumen fistulated lactating Holstein X Friesian dairy cows of second or greater parity and weighing from 550 to 800 kg were used for the study. Cows were 5 in mid lactation at the start of the study. Experimental diets: A single total mixed ration (TMR) diet was provided to all cows throughout the study. Cows were fed ad libitum (5% refusals) for the duration of the trial. 10 Experimental design: Beginning in mid lactation (with milk yields of 30 litres or more), the six cows were randomly assigned to one of the three supplement treat ments in a 3 x 3 Latin Square design (Table 8). Treatment periods were 5 weeks in duration. 15 Table 8. Experimental design Cow Pair 1 Pair 2 Pair 3 Square 1 Square 2 Period Cow 888 Cow 989 Cow 973 Cow 1000 Cow 1030 Cow 1060 1 1 2 3 1 2 3 2 2 3 1 2 3 1 3 3 1 2 3 1 2 Diets: 1- Control 2 - 3-Nitrooxypropanol (500 mg/day) 20 3 - 3-Nitrooxypropanol (2500 mg/day) Dosing of 3-Nitrooxypropanol or placebo: The doses of 3-Nitrooxypropanol or placebo was administered to the animals via the rumen cannula at feeding time in the morning and evening. 25 WO 2012/084629 - 40 - PCT/EP2011/072707 Period Design: As only two cows can be housed in the indirect calorimeters at any one time cows were run in pairs staggered by one week. At the end of week 4 animals were moved to the indirect calorimeters and held in individual tie stalls where four complete 24hr measurements of respiratory exchange (methane and 5 carbon dioxide production and oxygen consumption) were obtained (Cammell et al., 2000). Results 10 Feed Intake: There was no significant effect of the product (3-Nitrooxypropanol) on daily dry matter intake (DMI) (see table 9). Methane Production: Methane production (litres/d) and methane yield (litres/kg DMI) were significantly reduced by the 3-Nitrooxypropanol. Methane production was 15 93 and 90% of control values when the 500 and 2500 mg/d doses were given, re spectively (see table 9). As regards methane yield, the corresponding values were 96 and 93% of control methane yield, respectively, for the low and high doses. Table 9. Effects of DSM product fed at two doses. 20 Daily dose, mg/d 0 500 2500 SEM DMI, kg/d 18.9 18.8 18.5 0.7
CH
4 , L/d 594 555 536 15.3
CH
4 , g/d 425 398 384 11.0
CH
4 , L/kg DMI 31.3 29.9 29.2 1.2 Large variations were observed between animals some showing more response that some others. These results show the potential of the compounds of the present invention in reducing methane production in dairy cows, and shed light on further 25 improving the feeding regimen.

Claims (17)

1. Use of at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (1) 5 O2 N~y formula (I) wherein Y is an organic molecule of the following composition: CaHbOdNeSg, wherein 10 a is comprised between 1 and 25, b is comprised between 2 and 51, d is comprised between 0 and 8, e is comprised between 0 and 5, g is comprised between 0 and 3, 15 as an active compound in animal feeding for reducing the formation of methane emanating from the digestive activities of ruminants, and/or for improving ruminant performance, 20 wherein nitrooxy alkanoic acid, and/or derivatives thereof as defined by the formula (II) are excluded, 0 2 N, o O R2 z'R1 formula (II) 25 wherein u is comprised between 0 and 23 and, wherein if u ; 0, the carbon chain is a linear, a cyclic, or branched linear or cyclic aliphatic carbon chain which may be mono- or polyunsaturated and in any isomeric form, Z is independently 0, NH, or N-R3, wherein if R1 ; H, Z-R1- represents 30 an ester or a secondary amide derivative, 42 R1 is independently, hydrogen or a saturated straight, cyclic or branched chain of an alkyl or alkenyl group containing 1 to 10 carbon atoms, R2 is independently, hydrogen or a saturated straight or branched chain of an alkyl or alkenyl group containing 1 to 23 carbon atoms, and 5 R3 is independently, hydrogen or a saturated straight, cyclic or branched chain of an alkyl or alkenyl group containing 1 to 10 carbon atoms.
2. Use according to claim 1, wherein a is comprised between 1 and 10, 10 b is comprised between 2 and 21, d is comprised between 0 and 6, e is comprised between 0 and 3, g is comprised between 0 and 1. 15
3. Use according to claim 1, wherein the at least one organic molecule of for mula (1), is a compound of formula (111), 0 2 N, 0 R4 n Formula (Ill) 20 wherein n is comprised between 0 and 12, preferably comprised between 0 and 6 and, wherein, if n ; 0, the carbon chain is a linear, a cyclic, or branched aliphatic carbon chain which may be non substituted or sub stituted with up to 3 hydroxyl-, alkoxy-, amino-, alkylamino-, dial 25 kylamino- or nitrooxy groups, or an alkenyl, or alkynyl carbon chain mono- or polyunsaturated and in any isomeric form, R4 is independently, hydrogen or a saturated straight, cyclic or branched chain of an alkyl or alkenyl group containing 1 to 12, preferably 1 to 6 carbon atoms, 30 X is hydrogen, R5, R5-N, -0R5, -OCOR5, -NR5R6, -ON02, -COOR5, CONR5R6, -NHSO2R5, or -SO2NHR5, 43 R5 and R6 are independently, hydrogen, C1 -C12 straight, branched or cyclic alkyl chain, non substituted or substituted with up to 3 hydroxyl-, alkoxy-, amino-, alkylamino-, dialkylamino- or nitrooxy groups, alkenyl, or alkynyl carbon chain which may be mono or polyunsaturated, and in any isomeric 5 form.
4. Use according to any one of claims 1 to 3, wherein the at least one organic molecule of formula (I), or a salt thereof is selected from 3-Nitrooxypropanol, racemate-4-Phenylbutane-1,2-diyl dinitrate, 2-(Hydroxymethyl)-2 10 (nitrooxymethyl)-1,3-propanediol, N-Ethyl-3-nitrooxy-propionic sulfonyl amide,
5-Nitrooxy-pentanenitrile, 5-Nitrooxy-pentane, 3-Nitrooxy-propyl propionate, 1,3-bis-Nitrooxypropane, 1,4-bis-Nitrooxybutane, 1,5-bis-Nitrooxypentane, 3 Nitrooxy-propyl benzoate, 3-Nitrooxy-propyl hexanoate, 3-Nitrooxy-propyl 5 nitrooxy-hexanoate, Benzylnitrate, isosorbid-dinitrate, and N-[2 15 (Nitrooxy)ethyl]-3-pyridinecarboxamide, 2-Nitro-5-nitrooxymethyl-furan, and Bis-(2-nitrooxyethyl) ether. 5. Use according to any one of claims 1 to 4, wherein the at least one organic molecule of formula (I), or a salt thereof is selected from 3-Nitrooxypropanol, 5 20 Nitrooxy-pentanenitrile, 5-Nitrooxy-pentane, 3-Nitrooxy-propyl propionate, 1,3 bis-Nitrooxypropane, 1,4-bis-Nitrooxybutane, 1,5-bis-Nitrooxypentane, 3 Nitrooxy-propyl benzoate, 3-Nitrooxy-propyl hexanoate, 3-Nitrooxy-propyl 5 nitrooxy-hexanoate, isosorbid-dinitrate, and N-[2-(Nitrooxy)ethyl]-3 pyridinecarboxamide, and Bis-(2-nitrooxyethyl) ether. 25
6. Use according to any one of claims 1 to 5, wherein the at least one organic molecule of formula (1), is a mixture of 3-nitrooxy propanol and 1,3-bis nitrooxypropane. 30
7. Use according to any one of claims 1 to 6, wherein the at least one organic molecule of formula (I), or a salt thereof is combined with at least one additional active substance selected from the group consisting of diallyl disulfide, garlic oil, allyl isothiocyanate, deoxycholic acid, chenodeoxycholic acid and derivatives thereof. 44
8. Use according to any one of claims 1 to 7, wherein the ruminant animal is selected from the group consisting of: cattle, goats, sheep, giraffes, American Bison, European bison, yaks, water buffalo, deer, camels, alpacas, llamas, 5 wildebeest, antelope, pronghorn, and nilgai.
9. Use according to any one of claims 1 to 8, wherein the methane production in ruminants calculated in liters per kilogram of dry matter intake is reduced by at least 10 % when measured in metabolic chambers. 10
10. Use according to any one of claims 1 to 9, wherein the amount of the at least one active compound as defined in formula (1) administered to the ruminant animal is from 1 mg to 10 g per kg feed. 15
11. A ruminant feed composition or ruminant feed additive comprising at least one organic molecule of formula (1) wherein the compound of formula (1) is 3 nitrooxypropanol which is a mineral premix, a vitamin premix, or a premix including vitamins and minerals or a bolus. 20
12. A method for reducing the production of methane emanating from the digestive activities of ruminants and/or for improving ruminant animal performance comprising orally administering a sufficient amount of at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof as defined by formula (I) to the animal, 25 O2N y formula (I) wherein Y is an organic molecule of the following composition: CaHbOdNeSg, 30 wherein a is comprised between 1 and 25, b is comprised between 2 and 51, d is comprised between 0 and 8, 45 e is comprised between 0 and 5, g is comprised between 0 and 3, wherein nitrooxy alkanoic acid, and/or derivative thereof as defined by the 5 formula (II) are excluded, O2N, O 0 R2 z'R1 formula (II) wherein 10 u is comprised between 0 and 23 and, wherein if u ; 0, the carbon chain is a linear, a cyclic, or branched linear or cyclic aliphatic carbon chain which may be mono- or polyunsaturated and in any isomeric form, Z is independently 0, NH, or N-R3, wherein if R1 ; H, Z-R1 represents an ester or a secondary amide derivative, 15 R1 is independently, hydrogen or a saturated straight, cyclic or branched chain of an alkyl or alkenyl group containing 1 to 10 carbon atoms, R2 is independently, hydrogen or a saturated straight or branched chain of an alkyl or alkenyl group containing 1 to 23 carbon atoms, and R3 is independently, hydrogen or a saturated straight, cyclic or branched 20 chain of an alkyl or alkenyl group containing 1 to 10 carbon atoms.
13. A method according to claim 12, wherein the at least one organic molecule is administered to the animal in combination with at least one additional active substance selected from the group consisting of diallyl disulfide, garlic oil, allyl 25 isothiocyanate, deoxycholic acid, chenodeoxycholic acid and derivatives thereof.
14. A method according to claims 12 or claim 13, wherein the ruminant animal is selected from the group consisting of: cattle, goats, sheep, giraffes, American 30 Bison, European bison, yaks, water buffalo, deer, camels, alpacas, llamas, wildebeest, antelope, pronghorn, and nilgai. 46
15. A method according to any one of claims 12 to 14, wherein the amount of the at least one organic molecule as defined in formula (I) administered to the ruminant animal is from 1 mg to 10 g per kg feed. 5
16. A method according to any one of claims 12 to 15, wherein the methane production in ruminants calculated in liters per kilogram of dry matter intake is reduced by at least 10 % when measured in metabolic chambers. 10
17. Use according to claim 1 or a method according to claim 12, substantially as hereinbefore described, with reference to any one of the Examples.
AU2011347802A 2010-12-20 2011-12-20 Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance Active AU2011347802B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10195857.7 2010-12-20
EP10195857 2010-12-20
EP11178994 2011-08-26
EP11178994.7 2011-08-26
PCT/EP2011/072707 WO2012084629A1 (en) 2010-12-20 2011-12-20 Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

Publications (3)

Publication Number Publication Date
AU2011347802A1 AU2011347802A1 (en) 2013-05-09
AU2011347802A8 AU2011347802A8 (en) 2013-06-06
AU2011347802B2 true AU2011347802B2 (en) 2015-05-07

Family

ID=45722564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011347802A Active AU2011347802B2 (en) 2010-12-20 2011-12-20 Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

Country Status (13)

Country Link
US (2) US9266814B2 (en)
EP (1) EP2654455B1 (en)
JP (1) JP5984189B2 (en)
KR (1) KR101927553B1 (en)
CN (1) CN103260424B (en)
AU (1) AU2011347802B2 (en)
BR (1) BR112013015569B1 (en)
DK (1) DK2654455T3 (en)
ES (1) ES2707876T3 (en)
NZ (1) NZ610031A (en)
PL (1) PL2654455T3 (en)
RU (1) RU2578485C2 (en)
WO (1) WO2012084629A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013015569B1 (en) * 2010-12-20 2020-03-03 Dsm Ip Assets B.V. USE OF ORGANIC NITROOXI MOLECULES IN FOOD TO REDUCE METHANE EMISSION IN RUMINANTS AND / OR TO IMPROVE RUMINANT PERFORMANCE, NUTRITIONAL COMPOSITION OR NUTRITIONAL ADDITIVE TO RUMINANTS
WO2012160191A2 (en) 2011-05-26 2012-11-29 Dsm Ip Assets B.V. Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance
CN103070299B (en) * 2012-12-20 2014-05-14 西北农林科技大学 Immunonutrition block for yaks
WO2015018726A1 (en) * 2013-08-07 2015-02-12 Dsm Ip Assets B.V. Use of a feed composition for reducing methane emission in ru-minants, and/or to improve ruminant performance
KR101656929B1 (en) * 2014-06-02 2016-09-13 씨제이제일제당 (주) Feed additive composition for reducing methane gas produced by ruminant animals
WO2017137489A1 (en) 2016-02-12 2017-08-17 Dsm Ip Assets B.V. Anti-methanogenic compositions and uses thereof
EP3238720A1 (en) 2016-04-29 2017-11-01 DSM IP Assets B.V. Anti-methanogenic compositions and uses thereof
CN106173339A (en) * 2016-07-20 2016-12-07 南京农业大学 The application of glyceryl trinitrate
CN106165771A (en) * 2016-07-20 2016-11-30 南京农业大学 The application of 2,2 pairs of methyl 3 (nitrooxy) propanoic acid
WO2018091643A1 (en) 2016-11-18 2018-05-24 Dsm Ip Assets B.V. Powderous formulations
ES2898682T3 (en) * 2017-02-14 2022-03-08 Dsm Ip Assets Bv Storage stable formulations
BR112019016678B1 (en) * 2017-02-14 2023-12-05 Dsm Ip Assets B.V WATER DISPERSIBLE FORMULATIONS, AQUEOUS DISPERSION AND FOOD PRODUCTS
JP7019925B2 (en) * 2017-02-21 2022-02-16 ディーエスエム アイピー アセッツ ビー.ブイ. Use of feed compositions to reduce ruminant methane emissions and / or to improve ruminant performance
WO2018153702A1 (en) * 2017-02-21 2018-08-30 Dsm Ip Assets B.V. Use of a feed composition for reducing methane emission in rumi-nants, and/or to improve ruminant performance
WO2019007740A1 (en) * 2017-07-07 2019-01-10 Dsm Ip Assets B.V. Compressed tablets
WO2019121511A1 (en) 2017-12-18 2019-06-27 Dsm Ip Assets B.V. Storage stable mixtures
EP3727358A1 (en) * 2017-12-18 2020-10-28 DSM IP Assets B.V. Storage stable mixtures
CN111491517A (en) * 2017-12-18 2020-08-04 帝斯曼知识产权资产管理有限公司 Storage stable mixture, method for improving compound retention and use of rice hulls and/or rice bran for enhancing compound retention
WO2019121502A1 (en) 2017-12-18 2019-06-27 Dsm Ip Assets B.V. Storage stable mixtures
US20200367529A1 (en) 2017-12-18 2020-11-26 Dsm Ip Assets B.V. Storage stable mixtures
WO2019129506A1 (en) 2017-12-31 2019-07-04 Dsm Ip Assets B.V. Denitrifying enzymes
US20210071208A1 (en) 2017-12-31 2021-03-11 Dsm Ip Assets B.V. Selective production of 1,3-propanediol monoacetate
AU2019212738A1 (en) 2018-01-24 2020-07-23 Dsm Ip Assets B.V. Novel use
EP3743052A1 (en) 2018-01-24 2020-12-02 DSM IP Assets B.V. Novel use
EP3784647B1 (en) * 2018-04-25 2022-05-11 DSM IP Assets B.V. Novel dicarboxylic acid diesters
US11758925B2 (en) 2018-07-12 2023-09-19 Dsm Ip Assets B.V. Continuous production of an adsorption product of a nitrooxy-functional organic compound
EP3849340B1 (en) * 2018-09-14 2023-12-13 DSM IP Assets B.V. Process for the manufacture of omega nitrooxy-1-alkanols
EP3849961B1 (en) 2018-09-14 2023-08-30 DSM IP Assets B.V. Process for the manufacture of omega nitrooxy-1-alkanols
EP3628169A1 (en) 2018-09-25 2020-04-01 DSM IP Assets B.V. 3h-1,2-dithiol-derivatives for reducing methane emission in ruminants
MX2021004581A (en) * 2018-10-25 2021-06-15 Dsm Ip Assets Bv Aqueous compositions comprising omega nitrooxy-1-alkanols.
EP3662761B1 (en) 2018-12-04 2021-05-05 DSM IP Assets B.V. Storage stable adsorbates of nitrooxy-compounds
EP3669663A1 (en) 2018-12-17 2020-06-24 DSM IP Assets B.V. Novel beadlets
EP3718411A1 (en) 2019-04-04 2020-10-07 DSM IP Assets B.V. Novel beadlets
EP3718412A1 (en) 2019-04-04 2020-10-07 DSM IP Assets B.V. Novel beadlets
US20220192229A1 (en) * 2019-04-16 2022-06-23 Dsm Ip Assets B.V. Early life nutrition
WO2020221805A1 (en) * 2019-04-30 2020-11-05 Dsm Ip Assets B.V. Novel fatty acid esters
WO2021116395A1 (en) 2019-12-11 2021-06-17 Dsm Ip Assets B.V. New slow-release delivery composition
WO2021116396A1 (en) 2019-12-11 2021-06-17 Dsm Ip Assets B.V. Compressed tablets
CN115298287B (en) 2020-04-21 2024-05-14 组合化学工业株式会社 Methanogenesis inhibitor composition and method for inhibiting methanogenesis
EP4139276A1 (en) 2020-04-22 2023-03-01 DSM IP Assets B.V. Process for the preparation of omega-alkanediol mononitrate
CN117136302A (en) 2021-04-13 2023-11-28 帝斯曼知识产权资产管理有限公司 Method for monitoring use of methane inhibitors
CA3215285A1 (en) * 2021-04-15 2022-10-20 Dsm Ip Assets B.V. Use of gossypol and a methane inhibitor for reducing the formation of methane emanating from the digestive activities of ruminants
AU2022257259A1 (en) * 2021-04-15 2023-10-12 Dsm Ip Assets B.V. Novel use
WO2022218963A1 (en) 2021-04-15 2022-10-20 Dsm Ip Assets B.V. Novel use
US20240207203A1 (en) 2021-04-15 2024-06-27 Dsm Ip Assets B.V. Novel use
CN113575773A (en) * 2021-06-23 2021-11-02 中国农业科学院北京畜牧兽医研究所 Composition for improving rumen fermentation of ruminants and use thereof
EP4362698A1 (en) 2021-06-29 2024-05-08 Dansk Landbrugs Grovvareselskab A.m.b.a. Feed additive comprising iodoform for use in a method of reducing methane production in and/or for improving performance of a ruminant
EP4201222A1 (en) 2021-12-21 2023-06-28 Société des Produits Nestlé S.A. Combination of bornyl acetate and citral for decreasing enteric methane production in ruminants
US20240002726A1 (en) * 2022-07-01 2024-01-04 Arkea Bio Corp. Compositions and methods for reducing deleterious atmospheric gas emissions from flooded ecosystems
KR20240070303A (en) * 2022-11-14 2024-05-21 대한민국(농촌진흥청장) Composition for reducing methane emission from ruminants containing Thiamine triphosphate
WO2024126430A1 (en) 2022-12-14 2024-06-20 Dsm Ip Assets B.V. New method for sustainable manure management

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030013198A1 (en) * 2001-07-11 2003-01-16 Tsutomu Harada Taste recognition system and recognition method

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608087A (en) * 1968-06-21 1971-09-21 Merck & Co Inc Feed compositions
SU890961A3 (en) * 1976-01-20 1981-12-15 Циба-Гейги Аг (Фирма) Growth stimulating agent for animals
WO1986006960A2 (en) 1985-05-22 1986-12-04 Beecham Group P.L.C. Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
SU1687216A1 (en) * 1989-04-24 1991-10-30 Московская сельскохозяйственная академия им.К.А.Тимирязева A method of feeding livestock
NZ242592A (en) * 1991-05-13 1993-12-23 Merck & Co Inc PROCESS FOR CONVERTING 13#a# HYDROXY AVERMECTIN AGLYCONES TO THE 13#B#
JP3232193B2 (en) * 1994-06-02 2001-11-26 潤一 高橋 Ruminant feeding composition and method for improving ruminant feed efficiency
US20050137191A1 (en) 1996-06-04 2005-06-23 Thatcher Gregory R. Nitrate esters and their use for mitigating cellular damage
WO2001026482A1 (en) * 1999-10-14 2001-04-19 Dcv, Inc. Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals
JP4783512B2 (en) * 2001-03-27 2011-09-28 社団法人農林水産先端技術産業振興センター A feed composition that suppresses methane production in ruminants
JP5192108B2 (en) * 2001-09-19 2013-05-08 株式会社ヤクルト本社 Composition for inhibiting methanogenesis and composition for feed for ruminants
US8106080B2 (en) 2005-06-09 2012-01-31 Gu-Qi Wang Compositions and methods for enhancing nitric oxide delivery
US20070098796A1 (en) 2005-10-31 2007-05-03 Rekhi Gurvinder S Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
US20100179192A1 (en) 2007-07-09 2010-07-15 Nicox S.A. Use of nitric oxide releasing compounds in the treatment of chronic pain
ES2332859B1 (en) 2008-06-12 2010-09-22 Carotenoid Technologies, S.A. PROCEDURE TO IMPROVE THE GENERAL STATE OF RUMINANTS.
FR2933191B1 (en) 2008-06-25 2010-06-25 Valorisation Par Extrusion METHOD FOR EVALUATING THE QUANTITY OF METHANE PRODUCED BY A DAIRY RUMINANT AND METHOD FOR DECREASING AND CONTROLLING SUCH QUANTITY
WO2010072584A1 (en) 2008-12-23 2010-07-01 Dsm Ip Assets B.V. Bile acids in feed for reducing methane production emanating from the digestive activities of ruminants
JP2010200730A (en) * 2009-02-27 2010-09-16 Ajinomoto Co Inc Methanation inhibitor for ruminant and feed composition
UY32802A (en) 2009-07-23 2011-01-31 Provimi Holding B V COMPOSITIONS TO REDUCE GASTROINTESTINAL METANOGENESIS IN RUMINANTS
CN101611762B (en) * 2009-07-23 2011-12-28 中国农业大学 Compound quick-action inhibitor against generation of methane and preparation method and application thereof
BR112013015569B1 (en) * 2010-12-20 2020-03-03 Dsm Ip Assets B.V. USE OF ORGANIC NITROOXI MOLECULES IN FOOD TO REDUCE METHANE EMISSION IN RUMINANTS AND / OR TO IMPROVE RUMINANT PERFORMANCE, NUTRITIONAL COMPOSITION OR NUTRITIONAL ADDITIVE TO RUMINANTS
WO2012160191A2 (en) 2011-05-26 2012-11-29 Dsm Ip Assets B.V. Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030013198A1 (en) * 2001-07-11 2003-01-16 Tsutomu Harada Taste recognition system and recognition method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MORGAVI, D. P. et al., Animal, 2010, Vol. 4, No. 7, pages 1024-1036 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Also Published As

Publication number Publication date
RU2013133968A (en) 2015-01-27
BR112013015569B1 (en) 2020-03-03
PL2654455T3 (en) 2019-05-31
EP2654455B1 (en) 2018-10-24
US20150376113A1 (en) 2015-12-31
WO2012084629A1 (en) 2012-06-28
KR20130126642A (en) 2013-11-20
US9266814B2 (en) 2016-02-23
CN103260424B (en) 2016-05-11
AU2011347802A8 (en) 2013-06-06
US20140147529A1 (en) 2014-05-29
CN103260424A (en) 2013-08-21
ES2707876T3 (en) 2019-04-05
EP2654455A1 (en) 2013-10-30
US9902685B2 (en) 2018-02-27
AU2011347802A1 (en) 2013-05-09
NZ610031A (en) 2015-01-30
JP5984189B2 (en) 2016-09-06
RU2578485C2 (en) 2016-03-27
DK2654455T3 (en) 2019-02-18
BR112013015569A2 (en) 2016-07-19
JP2013545485A (en) 2013-12-26
KR101927553B1 (en) 2018-12-10

Similar Documents

Publication Publication Date Title
AU2011347802B2 (en) Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
AU2012260799B2 (en) Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance
EP2509435B1 (en) Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
AU2012260799A1 (en) Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance
EP3041365B1 (en) Use of a feed composition for reducing methane emission in ru-minants, and/or to improve ruminant performance
EP2830434B1 (en) Use of para nitro amino derivatives in feed for reducing me-thane emission in ruminants
NZ617849B2 (en) Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 27 , NO 17 , PAGE(S) 2719 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME DSM IP ASSETS B.V., APPLICATION NO. 2011347802, UNDER INID (71) CORRECT THE APPLICANT NAME TO DSM IP ASSETS B.V.

FGA Letters patent sealed or granted (standard patent)